GlassScriptPhysician profile
Eric O Aigbedion
NPI 1669472072
$2,072.64
in general payments reported to CMS, 2019-2025
17 companies · $254 in 2025
The $254 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $223 · 2021: $349 · 2022: $303 · 2023: $270 · 2024: $419 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $517.27 | 2019-2025 | Rybelsus, Ozempic |
| Vanda Pharmaceuticals INC. | $347.86 | 2020-2024 | Hetlioz, Fanapt |
| Astrazeneca Pharmaceuticals LP | $279.32 | 2019-2025 | Airsupra, Breztri |
| Lilly USA, LLC | $259.99 | 2020-2024 | Mounjaro, Trulicity |
| Redhill Biopharma INC. | $136.10 | 2020-2024 | Talicia |
| Exact Sciences Corporation | $127.96 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $127.04 | 2019-2025 | Repatha, Otezla, Repatha |
| Hologic Sales and Service, LLC | $48.51 | 2024-2025 | Aptima |
| Phathom Pharmaceuticals, INC. | $41.67 | 2024 | Voquezna |
| Glaxosmithkline, LLC. | $39.80 | 2023 | Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $33.80 | 2021-2023 | |
| Abbvie INC. | $29.37 | 2025 | |
| Genentech USA, INC. | $25.13 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.50 | 2019 | |
| Gilead Sciences, INC. | $15.89 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $13.91 | 2023 | Edarbi |
| Phadia US INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Aigbedion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.